Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates: an overview with special reference to alendronate.

S D Vasikaran1

  • 1Department of Core Clinical Pathology and Biochemistry, Royal Perth Hospital, WA, Australia. samuel.vasikaran@health.wa.gov.au

Annals of Clinical Biochemistry
|December 6, 2001
PubMed
Summary

Bisphosphonates inhibit bone resorption, impacting calcium and vitamin D levels. This can affect parathyroid hormone (PTH) interpretation, especially in patients with hypoparathyroidism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reference intervals for plasma β-CTX and P1NP in children: A systematic review and pooled estimates.

Clinical biochemistry·2023
Same author

Harmonization of commercial assays for PINP; the way forward.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case--control study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
Same author

The Clinical Biochemist Reviews: seeking international impact and influence.

The Clinical biochemist. Reviews·2008
Same author

The assessment of interpretation in clinical biochemistry: a personal view.

Annals of clinical biochemistry·2007
Same author

Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays.

Annals of clinical biochemistry·2006

Area of Science:

  • Pharmacology
  • Endocrinology
  • Bone Metabolism

Background:

  • Bisphosphonates are pyrophosphate analogues that inhibit osteoclast-mediated bone resorption.
  • They are clinically used for Paget's disease, hypercalcaemia, malignancy-related osteolytic bone disease, hyperparathyroidism, and osteoporosis.

Purpose of the Study:

  • To review the effects of bisphosphonate treatment on bone resorption, calcium homeostasis, and parathyroid hormone (PTH) levels.
  • To discuss the clinical implications of bisphosphonate-induced changes in calcium and PTH.
  • To highlight emerging research on bisphosphonates' effects on lipoprotein metabolism.

Main Methods:

  • Review of existing literature on bisphosphonate pharmacology and clinical effects.
  • Analysis of biochemical changes associated with bisphosphonate therapy, including serum calcium, PTH, and vitamin D.

Related Experiment Videos

  • Discussion of cellular mechanisms and potential new applications.

    • Main Results:

    • Bisphosphonate treatment initially reduces bone resorption, leading to decreased serum calcium.
    • Reduced serum calcium stimulates parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D, causing secondary hyperparathyroidism.
    • This hormonal response can complicate PTH interpretation and may cause severe hypocalcaemia in susceptible patients.

    Conclusions:

    • Bisphosphonates significantly alter bone and mineral metabolism, necessitating careful monitoring of calcium and PTH levels.
    • Understanding these effects is crucial for accurate diagnosis and management, particularly in patients with pre-existing endocrine conditions.
    • Further research into bisphosphonates' impact on lipoprotein metabolism may reveal new therapeutic avenues.